SUBSCRIBE

December 2014 Vol. 9 No. 12

Dosing strategy may reduce toxicity of TB treatment

Giving patients with tuberculosis (TB) lower doses of the bedaquiline together with verapamil might lead to the same antibacterial effects as higher toxic doses of bedaquiline, according to…

Ebola update

On Dec. 3, the Centers for Disease Control and Prevention updated information on the Ebola outbreak. Read more and access the list of hospital designated as Ebola treatment centers.

Ebola updates from FDA

The U.S. Food and Drug Administration (FDA) is working to help expedite the development and availability of medical product, such as treatments, vaccines, diagnostic tests, and personal protective…

FDA authorizes use of Ebola test

The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to authorize use of the LightMix® Ebola Zaire rRT-PCR Test for the presumptive detection…

FDA grants waiver for flu test

On January 6, the U.S. Food and Drug Administration (FDA) granted the first waiver to allow a nucleic acid-based test, the Alere i Influenza A & B test,…

Quiz Time

A patient who has had her final menstrual period tells you she is experiencing intermittent vaginal bleeding. You should tell the woman to: a. make an appointment with…

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

Survey
cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Poll